183061-37-2

Basic information

• Product Name: 7-Nitro-1-indanone
• Synonyms: 7-Nitro-1-indanone;2,3-Dihydro-7-nitro-1H-inden-1-one;7-nitro-2,3-dihydro-1H-inden-1-one
• CAS NO: 183061-37-2
• Molecular Formula: C9H7NO3
• Molecular Weight: 177.15678
• Mol File: 183061-37-2.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 335.4±31.0 °C(Predicted)
• Appearance: /
• Density: 1.396±0.06 g/cm3(Predicted)
• Refractive Index: 1.629
• CAS DataBase Reference: 7-Nitro-1-indanone(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Nitro-1-indanone(183061-37-2)
• EPA Substance Registry System: 7-Nitro-1-indanone(183061-37-2)

Safety Data

• Hazardous Substances Data: 183061-37-2(Hazardous Substances Data)

Usage

General Description

7-Nitro-1-indanone is a chemical compound that is widely used in the field of organic chemistry. It is a yellow crystalline solid with a chemical formula of C9H7NO3 and a molecular weight of 177.16 g/mol. It is a key building block in the synthesis of various pharmaceuticals and agrochemicals. 7-Nitro-1-indanone is known for its strong fluorescence properties, which make it useful in fluorescent labeling and imaging applications. Additionally, it has been studied for its potential antimicrobial and anticancer properties. As a versatile compound, 7-Nitro-1-indanone continues to be an important tool in the development of new and innovative chemical processes and applications.

InChI:InChI=1/C9H7NO3/c11-8-5-4-6-2-1-3-7(9(6)8)10(12)13/h1-3H,4-5H2

Relevant articles and documents

Vanilloid receptor ligands and their use in treatments

Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.